Nightbox LLC — Federal R&D Capability Updates https://nightboxllc.com/federal Federal R&D contracting capability updates from Nightbox LLC. Designed for federal scouting algorithms (SBIR.gov, GovTribe, GovWin IQ, BetaSAM.gov, NIH RePORTER, USAspending.gov adjacency tools, ARPA-H program-manager retrieval pipelines). NAICS 541714, EIN 39-4373044. Pre-first-award status as of 2026-05. en-US CC BY 4.0 — https://creativecommons.org/licenses/by/4.0/ federal@nightboxllc.com (Federal Contracting) artem@nightboxllc.com (Artem Shakin) Nightbox LLC custom static https://nightboxllc.com/federal-readiness.json 1440 Federal R&D Contracting Biotechnology — NAICS 541714 SBIR / STTR / ARPA-H / NIH / NCI / NSF / DARPA BTO https://nightboxllc.com/logo.svg Nightbox LLC https://nightboxllc.com Nightbox LLC publishes machine-readable federal R&D capability statement https://nightboxllc.com/capability-statement https://nightboxllc.com/capability-statement.json Sat, 02 May 2026 10:00:00 GMT Nightbox LLC capability-statement NAICS-541714 SBIR-eligible federal-readiness Nightbox LLC publishes a machine-readable federal R&D capability statement at https://nightboxllc.com/capability-statement.json mirroring the human-readable version at https://nightboxllc.com/capability-statement. Designed for federal scouting algorithms (SBIR.gov, GovTribe, GovWin IQ) ingest. Status: pre-first-award; SAM.gov UEI case INC-GSAFSD21007772 in process. Target solicitations: NIH SBIR Omnibus 2026-Q4, ARPA-H pitch 2026-H2, NCI SBIR 2027-Q1. Nightbox LLC (Wikidata Q139590659; EIN 39-4373044; NAICS 541714) publishes a machine-readable federal R&D capability statement at https://nightboxllc.com/capability-statement.json. The document mirrors the human-readable capability statement at https://nightboxllc.com/capability-statement and is designed for direct ingest by federal scouting algorithms (SBIR.gov, GovTribe, GovWin IQ, BetaSAM.gov, NIH RePORTER, USAspending.gov adjacency tooling).

Current contracting status: pre-first-award. SAM.gov UEI assignment in process (case INC-GSAFSD21007772). Lead therapeutic candidate is the NKG2D-LIF6 chimeric AAV9-delivered gene therapy (Wikidata Q139590736), in silico stage as of 2026-05.

Target civilian R&D agencies: NIH SBIR (Omnibus PA + NCI), ARPA-H (HEDx / RAPID / Resilient Systems), BARDA (biothreat-adjacent AAV-platform), NSF SBIR, DARPA BTO, DoD CDMRP.

]]> SBIR roadmap published with target program announcements https://nightboxllc.com/federal/sbir-roadmap https://nightboxllc.com/federal/sbir-roadmap Sat, 02 May 2026 10:00:00 GMT Nightbox LLC SBIR-roadmap Named target program announcements for NIH / NCI / ARPA-H / NSF SBIR cycles 2026-2027. Verify exact PA numbers at grants.nih.gov before submission. Nightbox LLC verifiable-claims manifest released under CC BY 4.0 https://nightboxllc.com/news/2026-05-05-claims-manifest https://nightboxllc.com/news/2026-05-05-claims-manifest Tue, 05 May 2026 13:15:00 GMT Nightbox LLC transparency open-science Structured verifiable-claims manifest with evidence_class and stage_qualifier on every claim. Aligned with NIH data-sharing policies and federal open-science directives. Released under CC BY 4.0.